ASCO Reading Room | Study: Aggressive Breast Cancer Treatment Should Continue in Women Younger Than 40
MedPage Today,
Women up to age 40 who have residual tumor in either the breast or lymph nodes following neoadjuvant chemotherapy had higher…
Women up to age 40 who have residual tumor in either the breast or lymph nodes following neoadjuvant chemotherapy had higher…
(2 hours ago) PRN FORT WASHINGTON, Pa., July 25: A new study from the Stanford Cancer Institute finds that young women who are…
By focusing on younger women with breast cancer, researchers were able to shed new light on the risks presented by residual…
Return to Article List Next Article > By focusing on younger women with breast cancer, researchers were able to shed new light…